Unknown PHASE1 INTERVENTIONAL 2-arm NCT01554293

Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

A Randomized, Double-Blind, Placebo-Controlled Phase I Study To Determine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

Sponsor: Panacea Biotec Ltd

Conditions Diabetes Mellitus

Interventions Matching placebo PBL 1427 capsules

Updated 6 times since 2017 Last updated: May 15, 2013 Started: Jul 31, 2012 Primary completion: Jul 31, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01554293, this PHASE1 trial focuses on Diabetes Mellitus and remains ongoing. Sponsored by Panacea Biotec Ltd, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Panacea Biotec Ltd

Data source: Panacea Biotec Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Faridabad, India